Gartner, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Gartner, Inc. (IT) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $79.11 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-04
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $79.11M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $79.46M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $80.19M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $80.34M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $79.11M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $79.46M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $80.19M 10-K · filed 2026-02-12 |
| 2025-09-30 | $80.34M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $80.06M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $79.19M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $81.07M 10-K · filed 2025-02-13 |
| 2024-09-30 | $82.61M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $81.31M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $81.26M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $90.14M 10-K · filed 2024-02-15 |
| 2023-09-30 | $89.24M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $90.11M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $89.16M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $90.77M 10-K · filed 2023-02-16 |
| 2022-09-30 | $95.90M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $98.21M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $100.07M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $100.69M 10-K · filed 2022-02-23 |
| 2021-09-30 | $101.24M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $101.77M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $96.17M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $105.94M 10-K · filed 2021-02-24 |
| 2020-09-30 | $104.11M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $103.59M 10-Q · filed 2020-08-04 |
| 2019-12-31 | $126.08M 10-K · filed 2020-02-19 |
| 2018-12-31 | $129.39M 10-K · filed 2019-02-22 |
| 2017-12-31 | $190.44M 10-K · filed 2018-02-22 |
| 2016-12-31 | $23.36M 10-K · filed 2017-02-22 |
| 2015-12-31 | $24.07M 10-K · filed 2016-02-24 |
| 2014-12-31 | $8.09M 10-K · filed 2015-02-27 |
| 2013-12-31 | $3.53M 10-K · filed 2014-02-26 |
| 2012-12-31 | $5.49M 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |